Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 7/2016

01-07-2016 | Correspondence

Hydroxocobalamin-attributed risk of oxalate nephropathy: evidence is not sufficient to change the recommended management of cyanide toxicity by fire smoke inhalation

Author: Bruno Mégarbane

Published in: Intensive Care Medicine | Issue 7/2016

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Legrand M, Michel T, Daudon M, Benyamina M, Ferry A, Soussi S, Maurel V, Chaussard M, Chaouat M, Mimoun M, Verine J, Mallet V, Mebazaa A, PRONOBURN Study Group (2016) Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients. Intensive Care Med. doi:10.​1007/​s00134-016-4252-4 PubMed
2.
3.
Thompson JP, Marrs TC (2012) Hydroxocobalamin in cyanide poisoning. Clin Toxicol (Phila) 50:875–885CrossRef
4.
Borron SW, Stonerook M, Reid F (2006) Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol (Phila) 44(Suppl 1):5–15CrossRef
5.
Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C (2007) Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 49:794–801CrossRefPubMed
Metadata
Title
Hydroxocobalamin-attributed risk of oxalate nephropathy: evidence is not sufficient to change the recommended management of cyanide toxicity by fire smoke inhalation
Author
Bruno Mégarbane
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 7/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4354-z

Other articles of this Issue 7/2016

Intensive Care Medicine 7/2016 Go to the issue

Correspondence

Vasopressor therapy: not like antibiotics!

Original

Nurses versus physician-led interhospital critical care transport: a randomized non-inferiority trial

Correspondence

Is the concept of fluid responsiveness evidence-based?

What's New in Intensive Care

Ten situations where inferior vena cava ultrasound may fail to accurately predict fluid responsiveness: a physiologically based point of view

Imaging in Intensive Care Medicine

Heart failure after acute myocardial infarction: giant pseudoaneurysm that was difficult to diagnose because of imaging techniques

Correspondence

Platelets and ECMO: should we worry about count, function, or both? Response to Mazzeffi and Tanaka